U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
BENRALIZUMAB
71492GE1FX
US Approved Rx (2017)
First approved in 2017
General
Names
11
Classification
8
Identifiers
15
Subunits
4
Related Substances
1
BENRALIZUMAB
71492GE1FX
US Approved Rx (2017)
First approved in 2017
General
Approval Year
2017
411
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
BENRALIZUMAB
Official Name
English
BIW-8405
Preferred Name
English
Benralizumab [WHO-DD]
Common Name
English
benralizumab [INN]
Common Name
English
MEDI-563
Code
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
8
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of Eosinophilic Gastritis (EG)
FDA ORPHAN DRUG
828221
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated
ORPHAN DRUG
Designated
Treatment of eosinophilic granulomatosis with polyangiitis
FDA ORPHAN DRUG
660018
Designated
ORPHAN DRUG
Designated
Treatment of eosinophilic esophagitis
FDA ORPHAN DRUG
670018
Designated
ORPHAN DRUG
Designated
Treatment of hypereosinophilic syndrome
FDA ORPHAN DRUG
670518
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Identifiers
15
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DRUG CENTRAL
5263
PRIMARY
NCI_THESAURUS
C88594
PRIMARY
DAILYMED
71492GE1FX
PRIMARY
SMS_ID
100000167493
PRIMARY
RXCUI
1989100
PRIMARY
Showing 1 to 5 of 15 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
71492GE1FX
BENRALIZUMAB
